智通财经APP获悉，美银证券发布研报称，预期阿里健康(00241)收入将由去年9月底止2025财年上半年同比增长10%，加速至今年3月底止2025财年下半年的同比增长15%，接近同业京东健康(06618)的增长16%预测。美银证券将阿里健康目标价由4.6港元上调至5.2港元，重申“买入”评级。
该行表示，维持对阿里健康截至今年3月底止2025财年业绩预测，高于市场共识及公司指引。当中，收入预计同比增长13%，高于市场预测及公司指引的分别增长12%及多于10%;经调整净利润预计同比增长46%，市场共识及公司指引分别为19.5亿及多于20亿元人民币。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.